Skip to search formSkip to main contentSkip to account menu

BCL-2 Inhibitor [EPC]

Known as: B-Cell Lymphoma-2 Inhibitor, B-Cell Lymphoma-2 Protein Inhibitor, Bcl 2 Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The aim of this study was to investigate the antioxidant and anti-apoptotic activities, as well as the underlying mechanisms of… 
2019
2019
Osteoblast apoptosis has been identified as an important event in the development of glucocorticoid (GC)-induced osteoporosis and… 
2019
2019
Butyrate, a histone deacetylase inhibitor, is a typical short chain fatty acid produced by gut microbiota, the dysmetabolism of… 
2019
2019
The aim of the present study was to determine the effects of ferulic acid (FerA) administered immediately following the onset of… 
Highly Cited
2018
Highly Cited
2018
Acute liver injury is characterized by fibrosis, inflammation and apoptosis, leading to liver failure, cirrhosis or cancer and… 
2018
2018
The present study aimed to investigate the protective effects of rhein on cerebral ischemic/reperfusion (I/R) injury in rats. The… 
2018
2018
The present study aimed to investigate molecular mechanisms associated with liver cancer and provide a possible therapeutic… 
2018
2018
Vascular endothelial apoptosis and dysfunction have a crucial role in triggering pathological vascular remodeling of hypoxia… 
2018
2018
The inhibition of mesangial cell (MC) proliferation has become an important therapy in preventing glomerular proliferation… 
2015
2015
AbstractPurpose The oral Bcl-2 inhibitor navitoclax demonstrated activity in solid and hematologic malignancies as monotherapy…